Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

26 juil. 2016 11h27 HE | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S - Passing of Extraordinary General Meeting

Company Announcement no. 17/2016 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, July...
01 juil. 2016 11h00 HE | Source: Veloxis Pharmaceuticals A/S

Notice to Convene Extraordinary General Meeting

Company Announcement no. 16 /2016 To: NASDAQ OMX Copenhagen A/S ...
30 juin 2016 03h00 HE | Source: Veloxis Pharmaceuticals A/S

Veloxis announces the total number of shares and voting rights in the company as of 30 June 2016

Company Announcement no. 15/2016 To: NASDAQ OMX Copenhagen...
28 juin 2016 22h33 HE | Source: Veloxis Pharmaceuticals A/S

Veloxis Receives Envarsus XR® Package Insert Label Enhancements Based on Study of African-American Transplant Recipients

Company Announcement no. 14/2016 To: NASDAQ OMX Copenhagen A/S ...
13 juin 2016 02h00 HE | Source: Veloxis Pharmaceuticals A/S

Veloxis increases share capital in connection with exercise of warrants

Company Announcement no. 13/2016 To: NASDAQ OMX Copenhagen...
08 juin 2016 09h21 HE | Source: Veloxis Pharmaceuticals A/S

Veloxis to Present Company Overview and Envarus® XR (tacrolimus extended-release tablets) Launch Update at Jefferies 2016 Healthcare Conference

Investor service announcement no. 4/2016 To: NASDAQ OMX Copenhagen...
31 mai 2016 12h00 HE | Source: Veloxis Pharmaceuticals A/S

Veloxis announces the total number of shares and voting rights in the company as of 31 May 2016

Company Announcement no. 12/2016 To: NASDAQ OMX Copenhagen...
30 mai 2016 02h00 HE | Source: Veloxis Pharmaceuticals A/S

Veloxis increases share capital in connection with exercise of warrants

Company Announcement no. 11/2016 To: NASDAQ OMX Copenhagen...
19 mai 2016 14h29 HE | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S establishes new Warrant Programme

Company Announcement no. 10/2016 To: NASDAQ Copenhagen...
18 mai 2016 12h00 HE | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals announces financial results for the first three months of 2016

Company Announcement no. 9/2016 To: NASDAQ OMX Copenhagen...

Page précédente